Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2989 USD | +1.67% | -8.59% | +77.92% |
May. 14 | Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
Apr. 02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 |
Financials (USD)
Sales 2024 * | 19.05M | Sales 2025 * | 25.76M | Capitalization | 87.02M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | - | EV / Sales 2024 * | 4.57 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.38 x |
P/E ratio 2024 * |
-29.4
x | P/E ratio 2025 * |
-
| Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.81% |
Latest transcript on BioLargo, Inc.
1 day | +1.67% | ||
1 week | -8.59% | ||
Current month | -10.08% | ||
1 month | -14.96% | ||
3 months | -0.43% | ||
6 months | +75.93% | ||
Current year | +77.92% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Charles Dargan
DFI | Director of Finance/CFO | 68 | 08-01-31 |
Chief Operating Officer | 55 | 02-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.2989 | +1.67% | 93 777 |
24-05-22 | 0.294 | +0.67% | 288,132 |
24-05-21 | 0.292 | -4.09% | 445,081 |
24-05-20 | 0.3045 | -4.09% | 310,130 |
24-05-17 | 0.3175 | -2.91% | 367,275 |
Delayed Quote OTC Markets, May 23, 2024 at 03:43 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.92% | 87.02M | |
+3.18% | 104B | |
-8.02% | 62.39B | |
+72.86% | 48.95B | |
+15.97% | 39.58B | |
+2.46% | 32.08B | |
+11.96% | 20.22B | |
+11.78% | 16.86B | |
+14.58% | 14.88B | |
+0.77% | 13.99B |
- Stock Market
- Equities
- BLGO Stock